Ph3 Study of (EPCORE FL-2) in previously untreated follicular lymphoma
Phase III Clinical Trial
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCOREFL-2) (M22-003)